-
Mashup Score: 224t(6;9)(p22;q34) DEK/NUP214 - 2 day(s) ago
Please, confirm that you want to generate a PDF file of this page. This may take some seconds once process has started. Then it will be opened automatically.
Source: atlasgeneticsoncology.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10Sign the Petition - 3 day(s) ago
Eliminate ABIMs MOC requirement
Source: www.change.orgCategories: General Medicine News, Hem/OncsTweet-
@VPrasadMDMPH Sign the petition https://t.co/JKZF57DFlH
-
-
Mashup Score: 1222025 update on clinical trials in immune thrombocytopenia - 27 day(s) ago
Summary of major novel and repurposed agents currently in clinical development for immune thrombocytopenia.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
Time to get my classical heme on for a tough case of refractory ITP. This seems like a solid up to date review (also free) @Bloodman American Journal of Hematology | Blood Research Journal | Wiley Online Library https://t.co/aaOOox1uN5
-
-
Mashup Score: 75
The goal of this research study is to test if ciltacabtagene autoleucel (cilta-cel) is safe and effective in treating participants with high-risk, smoldering myeloma. The names of the treatment interventions used in this study are: – Cilta-cel (or chimeric antigen receptor T cells) – Cyclophosphamide (a lymphodepleting chemotherapy) – Fludarabine (a lymphodepleting chemotherapy)
Source: www.dana-farber.orgCategories: General Medicine News, Hem/OncsTweet-
The US medical system in all its glory! You can you be completely healthy, get a lab test checked you never needed, and end up receiving a toxic million dollar therapy with risks of secondary cancers and long term neurologic side effects. CAR-PRISM https://t.co/OGkPp1s431
-
-
Mashup Score: 38Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma - 1 month(s) ago
Key Points. SOC cilta-cel in RRMM results in deep and durable response despite over half the patients not meeting CARTITUDE-1 eligibility criteria.Close su
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Cilta cel in real world 10% non relapse mortality with only 13 month follow up. Sounds like an excellent drug for smoldering myeloma and frontline Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma https://t.co/x1m8kiywwv
-
-
Mashup Score: 18Public Health Sex Party Hypocrisy - 1 month(s) ago
The VPZD Show · Episode
Source: open.spotify.comCategories: General Medicine News, Hem/OncsTweet-
This episode was hilarious. Got me through an hour run. @VPrasadMDMPH https://t.co/6H8eCAX4NV
-
-
Mashup Score: 62eClinPath | A Resource for Veterinary Clinical Pathology - 2 month(s) ago
Welcome to eClinPath, an online textbook on Veterinary Clinical Pathology The goal of this site is to be an educational resource on veterinary clinical pathology – an “on-line” textbook as it were. We hope this will be a valuable resource, as are the several available paper textbooks on this discipline. We continually strive to update and […]
Source: eclinpath.comCategories: General Medicine News, Hem/OncsTweet-
Happy Halloween! Image from https://t.co/ZF5JMiGmtD https://t.co/6GBMmq0XVu
-
-
Mashup Score: 62eClinPath | A Resource for Veterinary Clinical Pathology - 2 month(s) ago
Welcome to eClinPath, an online textbook on Veterinary Clinical Pathology The goal of this site is to be an educational resource on veterinary clinical pathology – an “on-line” textbook as it were. We hope this will be a valuable resource, as are the several available paper textbooks on this discipline. We continually strive to update and […]
Source: eclinpath.comCategories: General Medicine News, Hem/OncsTweet-
Happy Halloween! Image from https://t.co/ZF5JMiGmtD https://t.co/6GBMmq0XVu
-
-
Mashup Score: 227News & Notes: Fall 2024 - 2 month(s) ago
The Longitudinal Knowledge Assessment (LKA®): Enrollment now open in 17 specialties; How does ABIM create assessment questions?; Has your practice changed?; You can deactivate your certificate in that discipline; Study finds new Milestones Rating System reduces but does not eliminate bias in residency knowledge ratings; How the physician community informs ABIM’s programs; Research Roundup
Source: blog.abim.orgCategories: General Medicine News, Hem/OncsTweet-
ABIM has eliminated 2 year MOC points! In case not everyone is an avid reader of the ABIM blog I provided a link Hopefully next on their list of elimination is LKA and 10 year recertification. @doctorwes @VincentRK @chadinabhan https://t.co/E746alDmfL https://t.co/Y9LB2Z0D3g
-
-
Mashup Score: 9Ain't It A Shame (Demo) - 2 month(s) ago
Provided to YouTube by Universal Music GroupAin’t It A Shame (Demo) · NirvanaWith The Lights Out – Box Set℗ 2004 Sub Pop RecordsReleased on: 2011-01-01Produc…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
Nirvana playing a blues song They rocked it https://t.co/5iO9JObxSC
-
AML Heme Path Pearl! AML with t(6;9) [DEK-NUP214] 1% of AMLs Associated with basophilia! Frequent FLT3 ITD mutations Poor prognosis (5 year OS = 30%) Rx = intensive induction +/- FLT3 inhibitor or ven/aza Consolidate = allogeneic transplant if able. https://t.co/LDmZ7I09oZ https://t.co/WUK4n4dgLb